Day One Biopharmaceuticals, Inc. (DAWN)

NASDAQ: DAWN · Real-Time Price · USD

6.76

-0.43 (-5.98%)

At close: Apr 16, 2025, 4:00 PM

6.82

+0.06 (0.89%)

After-hours: Apr 17, 2025, 4:10 PM EDT

DAWN Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Revenue	131.16	-	-	-	-	Upgrade
Cost of Revenue	5.28	-	-	-	-	Upgrade
Gross Profit	125.88	-	-	-	-	Upgrade
Selling, General & Admin	115.45	75.54	61.29	29.16	4.68	Upgrade
Research & Development	222.7	130.52	85.62	43.58	9.1	Upgrade
Operating Expenses	338.15	206.06	146.91	72.74	13.78	Upgrade
Operating Income	-212.27	-206.06	-146.91	-72.74	-13.78	Upgrade
Interest Expense	-	-	-	-	-0.03	Upgrade
Interest & Investment Income	19.7	17.19	4.75	0	-	Upgrade
Other Non Operating Income (Expenses)	109.22	-0.04	-0.02	-0.02	-30.03	Upgrade
EBT Excluding Unusual Items	-83.35	-188.92	-142.18	-72.75	-43.84	Upgrade
Other Unusual Items	-5	-	-	-	-	Upgrade
Pretax Income	-88.35	-188.92	-142.18	-72.75	-43.84	Upgrade
Income Tax Expense	7.14	-	-	-	-	Upgrade
Earnings From Continuing Operations	-95.5	-188.92	-142.18	-72.75	-43.84	Upgrade
Minority Interest in Earnings	-	-	-	2.11	3.34	Upgrade
Net Income	-95.5	-188.92	-142.18	-70.65	-40.51	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	99.99	-	Upgrade
Net Income to Common	-95.5	-188.92	-142.18	-170.64	-40.51	Upgrade
Shares Outstanding (Basic)	93	80	65	37	6	Upgrade
Shares Outstanding (Diluted)	93	80	65	37	6	Upgrade
Shares Change (YoY)	16.87%	21.85%	77.13%	568.42%	-6.67%	Upgrade
EPS (Basic)	-1.02	-2.37	-2.17	-4.62	-7.33	Upgrade
EPS (Diluted)	-1.02	-2.37	-2.17	-4.62	-7.33	Upgrade
Free Cash Flow	-80.28	-147.08	-109.9	-48.54	-13.58	Upgrade
Free Cash Flow Per Share	-0.86	-1.84	-1.68	-1.31	-2.46	Upgrade
Gross Margin	95.97%	-	-	-	-	Upgrade
Operating Margin	-161.84%	-	-	-	-	Upgrade
Profit Margin	-72.81%	-	-	-	-	Upgrade
Free Cash Flow Margin	-61.21%	-	-	-	-	Upgrade
EBITDA	-210.71	-206.03	-146.85	-72.72	-13.77	Upgrade
EBITDA Margin	-160.65%	-	-	-	-	Upgrade
D&A For EBITDA	1.56	0.04	0.06	0.02	0.02	Upgrade
EBIT	-212.27	-206.06	-146.91	-72.74	-13.78	Upgrade
EBIT Margin	-161.84%	-	-	-	-	Upgrade
Revenue as Reported	131.16	-	-	-	-	Upgrade

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q